FB Pixel no scriptChina’s top drugmaker jumps on HK listing
MENU
KrASIA
May
23

China’s top drugmaker jumps on HK listing

just now
Shares of China’s largest drugmaker, Hengrui Pharmaceuticals, opened 29% higher in its Hong Kong debut after raising HKD 9.9 billion, making it one of the year’s largest listings. The proceeds will support its global R&D in oncology, cardiometabolic, and neurological drugs, as the firm seeks its first overseas approvals. The IPO adds momentum to Hong Kong’s rebounding capital markets.
Share

Latest Pulses

See All

Most Recent